EGA Q&A on the Revised EMA Bioequivalence Requirement

To view the full report, please click here.

Generic Medicines: Essential Contributor to the Long-Term Health of Society

essential_contributor

Patent-Related Barriers to Market Entry for Generic Medicines in the European Union

patent_related_barriers

How to Increase Patient Access to Generic Medicines

how_to_increase_patient_acess_to_generic_medicines